<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="article-31355" content-type="chapter" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">statpearls</book-id>
    <book-title-group>
      <book-title>StatPearls</book-title>
    </book-title-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <month>01</month>
      <year>2024</year>
    </pub-date>
    <publisher>
      <publisher-name>StatPearls Publishing</publisher-name>
      <publisher-loc>Treasure Island (FL)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 2024, StatPearls Publishing LLC</copyright-statement>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/">
        <license-p>
This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0)
(<ext-link xlink:href="https://creativecommons.org/licenses/by-nc-nd/4.0/" ext-link-type="uri">
http://creativecommons.org/licenses/by-nc-nd/4.0/
</ext-link>), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.
</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="disclaimer">
      <p>The intent of StatPearls review books and articles is to identify knowledge deficits and assist you in the learning process. Review books and articles are not intended to be a source of the knowledge base of medicine. The authors and editors do not warrant the information is complete or accurate. The reader is encouraged to verify content and questions in several references. All drug indications and dosages should be verified before administration.</p>
      <p>The authors and editors would like to extend special thanks to Erin Hughes and Gerson Rubio for their editorial support.</p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <title-group>
        <title>White Matter Lesions</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sharma</surname>
            <given-names>Roopa</given-names>
          </name>
          <aff>Maulana Azad Medical College, New Delhi, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Sekhon</surname>
            <given-names>Sandeep</given-names>
          </name>
          <aff>Delhi University/Maulana Azad Medical College, New Delhi, India</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Lui</surname>
            <given-names>Forshing</given-names>
          </name>
          <aff>CA Northstate Uni, College of Med</aff>
        </contrib>
      </contrib-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Cascella</surname>
            <given-names>Marco</given-names>
          </name>
          <aff>Istituto Nazionale Tumori - IRCCS - Fondazione Pascale, Via Mariano Semmola 80100, Napoli. Italy</aff>
        </contrib>
      </contrib-group>
      <author-notes>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Roopa Sharma declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Sandeep Sekhon declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Forshing Lui declares no relevant financial relationships with ineligible companies.</p>
        </fn>
        <fn fn-type="COI-statement">
          <p><bold>Disclosure: </bold>Marco Cascella declares no relevant financial relationships with ineligible companies.</p>
        </fn>
      </author-notes>
      <pub-history>
        <date date-type="updated">
          <day>7</day>
          <month>3</month>
          <year>2024</year>
        </date>
      </pub-history>
    </book-part-meta>
    <body>
      <sec id="article-31355.s1" sec-type="Continuing Education Activity">
        <title>Continuing Education Activity</title>
        <p>White matter lesions, visualized as hyperintensities on magnetic resonance imaging (MRI) scans, signify abnormal myelination in the brain and serve as markers for small vessel disease. They are considered a marker of small vessel disease. However, there are numerous non-vascular causes, as well. An increase in white matter lesions increases the risk of stroke, cognitive decline, depression, disability, and mortality in the general population.</p>
        <p>Participants thoroughly examine white matter lesion pathophysiology, encompassing vascular and non-vascular contributors. The course offers detailed reviews of MRI imaging modalities, including T2 weighted and fluid-attenuated inversion recovery sequences that elucidate diagnostic nuances. Treatment strategies tailored to the underlying etiology are examined, aiming to mitigate associated risks such as stroke, cognitive decline, and depression. Engagement in this course fosters collaboration among healthcare professionals, emphasizing the crucial role of the interprofessional team in evaluating and managing patients with white matter lesions. By drawing on diverse expertise, including neurologists, radiologists, and primary care providers, clinicians can effectively navigate the complexities of diagnosis and treatment, ultimately enhancing patient outcomes and quality of life.</p>
        <p>
<bold>Objectives:</bold>
<list list-type="bullet"><list-item><p>Identify white matter lesions on neuroimaging studies by interpreting magnetic resonance imaging and computed tomography scans.</p></list-item><list-item><p>Interpret&#x000a0;the patient presentation associated with various diseases presenting white matter lesions and assess their pathophysiology.</p></list-item><list-item><p>Evaluate the progression and impact of white matter lesions on cognitive and functional abilities, utilizing standardized neuropsychological assessments and functional status evaluations.</p></list-item><list-item><p>Apply effective interprofessional team strategies&#x000a0;to improve&#x000a0;and enhance care delivery for patients with white matter lesions.</p></list-item></list>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31355&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31355">Access free multiple choice questions on this topic.</ext-link>
</p>
      </sec>
      <sec id="article-31355.s2" sec-type="pubmed-excerpt">
        <title>Introduction</title>
        <p>The brain's white matter (WM) constitutes a network of nerve fibers that allows the exchange of information and communication between different areas of the gray matter (GM). WM lies beneath the GM in the brain and superficial to GM in the spinal cord and has evolved more than GM and occupies almost half of the brain.<xref ref-type="bibr" rid="article-31355.r1">[1]</xref>&#x000a0;The size of white matter varies depending on the extent of central GM in different regions of spinal cord cross-sections. In particular, the GM to WM ratio grows from the cervical region to the lumbar region as the WM decreases when it proceeds towards the terminal portion of the spinal cord.</p>
        <p>The WM contains neural networks formed by bundles of axons to mediate essential connectivity between different key motor and cognitive cortical regions. The white matter comprises myelinated and unmyelinated axons and glial cells, including myelin-producing oligodendrocytes, microglia, astrocytes, and oligodendrocyte progenitor cells. Myelin acts as electrical insulation for axons, is responsible for rapid saltatory impulse propagation, and protects the nerve fibers from injury.<xref ref-type="bibr" rid="article-31355.r2">[2]</xref>&#x000a0;Myelin has a water content of about 40%. The remaining dry mass (60%) is mainly composed of proteins (15% to 30%) and lipids (70% to 85%), with phospholipids, cholesterol, galactolipids, and plasmalogens in a molar ratio of 2:2:1:1, respectively.<xref ref-type="bibr" rid="article-31355.r3">[3]</xref></p>
        <p>WM lesions or leukoaraiosis encompasses small vessel vascular brain diseases and non-vascular conditions. Any process leading to a change in chemical composition, damage, or ischemia of myelinated fibers can present as white matter lesions on magnetic resonance imaging (MRI), representing the gold standard for lesion investigation. WM hyperintensity (WMH) is quite a descriptive expression used on MRI. These lesions are best seen as hyperintensities on T2 weighted and FLAIR (fluid-attenuated inversion recovery) sequences of MRI. FLAIR sequences are particularly important in assessing white matter lesions near the ventricular margin by nullifying the cerebrospinal fluid signal.</p>
        <p>While the WMHs are well-described on MRI, the lesions were first illustrated based on brain computed tomography (CT). In 1985, Hachinski 1985 described "leukoaraiosis" as "diminished density of white matter that is seen on brain computed tomography."<xref ref-type="bibr" rid="article-31355.r4">[4]</xref>&#x000a0;Concerning small vessel vascular brain processes, white matter lesions are commonly present in MRI of asymptomatic elderly individuals, typically located in periventricular (PV-WMH) and deep subcortical regions (DS-WMH). For instance, white matter lesions are frequently detected in people with untreated chronic hypertension. The volume of white matter lesions increases with age from small punctate lesions to large confluent lesions. Nevertheless, although white matter lesions were initially considered a normal, age-related finding, recent investigations proved that large areas of disease in the brain's WM must be considered neuroimaging markers of brain frailty. Of note, various longitudinal studies described white matter lesions as a predictor for future risk of stroke, cognitive decline, depression, disability, and mortality in the general population.<xref ref-type="bibr" rid="article-31355.r5">[5]</xref><xref ref-type="bibr" rid="article-31355.r6">[6]</xref>&#x000a0;The clinical significance of the lesions is confirmed by the results of a meta-analysis that demonstrated a 3-fold increased risk of dementia and stroke and a doubled risk of death in people with white matter lesions.<xref ref-type="bibr" rid="article-31355.r7">[7]</xref>&#x000a0;For instance, ischemic microvascular disease, a vascular cause of white matter lesions, may cause about 45% of dementia cases and 20% of strokes. Again, white matter lesions are associated with poor post-stroke outcomes and increased risk of parenchymal hematoma following mechanical thrombectomy.<xref ref-type="bibr" rid="article-31355.r8">[8]</xref><xref ref-type="bibr" rid="article-31355.r9">[9]</xref></p>
        <p>Apart from white matter lesions secondary to small vessel disease, these lesions are also common features of demyelinating inflammatory disorders, leukodystrophies, and degenerative disorders. Clinical aspects, prognosis, and management vary according to the distribution and spread of the WM damage. Therefore, this group of lesions and diseases includes very different clinical conditions regarding etiology, pathogenesis, pathological features, clinical presentations, imaging, and therapy.&#x000a0;</p>
      </sec>
      <sec id="article-31355.s3" sec-type="Etiology">
        <title>Etiology</title>
        <p>The etiology of white matter lesions is heterogeneous. Based on etiology, they can be divided into vascular and non-vascular causes.</p>
        <p>
<bold>Vascular Causes of White Matter Lesions</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Microvascular ischemic disease or small vessel disease&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Atherosclerosis</p>
          </list-item>
          <list-item>
            <p>Migraine</p>
          </list-item>
          <list-item>
            <p>Amyloid angiopathy</p>
          </list-item>
          <list-item>
            <p>Cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Vasculitis</p>
          </list-item>
          <list-item>
            <p>Susac syndrome</p>
          </list-item>
        </list>
        <p>
<bold>Non-Vascular Causes for White Matter Lesions</bold>
</p>
        <list list-type="bullet">
          <list-item>
            <p>Inflammatory: Multiple sclerosis, acute disseminated encephalomyelitis, and neuromyelitis optica spectrum disorders&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Infectious: Human immunodeficiency virus encephalopathy, progressive multifocal leukoencephalopathy, neuroborreliosis, herpes simplex virus, cytomegalovirus encephalitis, neurosyphilis, central nervous system cryptococcal infection, Whipple disease, Lyme encephalopathy, subacute sclerosing panencephalitis.&#x000a0;</p>
          </list-item>
          <list-item>
            <p>Toxic: Chronic alcohol abuse, carbon monoxide intoxication, inhalation of toluene, heroin, and cocaine, methotrexate-related leukoencephalopathy.</p>
          </list-item>
          <list-item>
            <p>Metabolic: Vitamin B12 deficiency, copper deficiency, acute intermittent porphyria, hepatic encephalopathy, Hashimoto encephalopathy.</p>
          </list-item>
          <list-item>
            <p>Neoplastic: Glial tumors, central nervous system, lymphoma</p>
          </list-item>
          <list-item>
            <p>Traumatic: Radiotherapy, post-concussion (traumatic axonal injury)</p>
          </list-item>
          <list-item>
            <p>Genetic:&#x000a0;</p>
          </list-item>
          <list-item>
            <list list-type="bullet">
              <list-item>
                <p>Lysosomal storage diseases: Metachromatic leukodystrophy, Krabbe disease, Fabry disease, gangliosidosis, mucopolysaccharidosis</p>
              </list-item>
              <list-item>
                <p>Peroxisomal disorders: X-linked adrenoleukodystrophy, Zellweger syndrome, Refsum disease</p>
              </list-item>
              <list-item>
                <p>Mitochondrial disorders: Myoclonic epilepsy with ragged red fibers, mitochondrial encephalopathy, lactic acidosis, and stroke-like episodes, Leigh disease, Kearns-Sayre disease</p>
              </list-item>
              <list-item>
                <p>Aminoacidopathies and organic acidopathies: Canavan disease, glutaric aciduria, urea cycle disorders</p>
              </list-item>
              <list-item>
                <p>Unknown etiology: Alexander disease, Vander Knapp encephalopathy</p>
              </list-item>
              <list-item>
                <p>Others: Vanishing white matter disease, myotonic dystrophy</p>
              </list-item>
            </list>
          </list-item>
        </list>
        <p>Another nosographic approach distinguishes primary white matter lesions, derived from an unknown etiology, from secondary ones; these latter are due to a great variety of known etiologies.</p>
      </sec>
      <sec id="article-31355.s4" sec-type="Epidemiology">
        <title>Epidemiology</title>
        <p>The prevalence of age-related vascular white matter lesions in the general population is approximately 10% to 20% at 60 years and approaches 100% in those older than 90 years.<xref ref-type="bibr" rid="article-31355.r10">[10]</xref>&#x000a0;Studies have reported that white matter lesions are common in Japanese, Chinese, Caucasian, African-American, and Caribbean Black populations.<xref ref-type="bibr" rid="article-31355.r11">[11]</xref>&#x000a0;Multiple sclerosis (MS) represents the most common inflammatory neurological condition in young adults. Again, it has been estimated that MS disease affects approximately 2,500,000 people worldwide. In the US, the rate is 57 to 78 cases per 100,000 people in the southern states and 100 to 140 cases in the northern states.<xref ref-type="bibr" rid="article-31355.r12">[12]</xref>&#x000a0;The prevalence of neuromyelitis optica spectrum disorder (NMOSD) is approximately 1 in 100,000 in the White population and up to 10 per 100,000 in Black populations. In East Asians, the prevalence of NMOSD is about 3.5 per 100,000 population.<xref ref-type="bibr" rid="article-31355.r13">[13]</xref></p>
        <p>Progressive multifocal leukoencephalopathy (PML) is present in 1% to 4% of patients with acquired immunodeficiency syndrome. PML is also a rare yet severe complication of immunosuppression, such as in organ transplant patients. Furthermore, gliomas account for up to 35% of CNS tumors in adolescents and young adults.<xref ref-type="bibr" rid="article-31355.r14">[14]</xref>&#x000a0;The incidence of white matter lesions secondary to heritable WM disorder or leukodystrophy is approximately 1 per 8000 live births.<xref ref-type="bibr" rid="article-31355.r15">[15]</xref>&#x000a0;However, for acquired WM disorders in children, it is estimated to be 1.66 per 100,000 children.<xref ref-type="bibr" rid="article-31355.r16">[16]</xref></p>
      </sec>
      <sec id="article-31355.s5" sec-type="Pathophysiology">
        <title>Pathophysiology</title>
        <p>Cerebrovascular risk factors such as age, hypertension, diabetes mellitus, hyperlipidemia, hyperhomocysteinemia, and hypersensitive C-reactive protein are well-known risk factors for vascular white matter lesions.<xref ref-type="bibr" rid="article-31355.r11">[11]</xref>&#x000a0;Genetic factors also play an essential role in developing white matter lesions, as many genetic loci have been identified, and twin studies have suggested 55% to 80% heritability.<xref ref-type="bibr" rid="article-31355.r17">[17]</xref><xref ref-type="bibr" rid="article-31355.r18">[18]</xref>&#x000a0;</p>
        <p>Pathophysiology for developing vascular white matter lesions in older patients is thought to be secondary to chronically reduced blood flow by arteriosclerosis, lipohyalinosis, or fibrinoid necrosis of small vessels. Incomplete infarction secondary to persistent hypoxia leads to altered cerebral autoregulation, promoting the transcription of many inflammatory genes, leading to the breakdown of the blood-brain barrier and entry of pro-inflammatory proteins into the brain parenchyma and vessel wall. This breakdown will lead to demyelination, axonal loss, vacuolation, and reduced glial density. Results from some studies also suggest the role of venous collagen deposition in the pathogenesis of ischemic white matter lesions.<xref ref-type="bibr" rid="article-31355.r19">[19]</xref>&#x000a0;</p>
        <p>The different distribution of the lesions could be linked to different pathogenetic mechanisms. Periventricular-white matter hyperintensity (PV-WMH) is featured by gliosis, loosening of the WM, and loss around convoluted venules in perivascular spaces. In contrast, the primary characteristics of deep subcortical-white matter hypersensitivity (DS-WMH) are demyelination, gliosis, and augmented tissue loss as the lesions become serious. By summarizing, the pathological characteristics of white matter lesions may encompass myelin rarefaction, reactive gliosis, axonal loss, infarction, venular collagenosis, and arteriosclerotic small vessel alterations. Moreover, blood-brain barrier impairment plays a pivotal role in the genesis of WM damage, and a different pattern involves PV-WMH and DS-WMH.<xref ref-type="bibr" rid="article-31355.r20">[20]</xref></p>
        <p>In white matter lesions secondary to non-vascular diseases like MS, demyelination is caused by autoimmune inflammation-mediated primarily by T cells against myelin proteins.<xref ref-type="bibr" rid="article-31355.r21">[21]</xref>&#x000a0;While the cause of MS is still unknown, it probably presupposes a combination of genetic susceptibility and nongenetic factors such as viral infection and low vitamin D levels. This combination results in an autoimmune disorder that leads to myelin loss, destruction of oligodendrocytes, and reactive astrogliosis. However, the axon is usually undamaged; in some patients, it is aggressively destroyed.<xref ref-type="bibr" rid="article-31355.r22">[22]</xref></p>
        <p>NMOSD is a group of inflammatory disorders of the CNS featuring severe immune-mediated demyelination and axonal damage, mainly involving optic nerves and the spinal cord. Although these disorders were studied as a variant of MS, they have distinct pathophysiology. The autoimmune pathogenesis for NMOSD involves immunoglobulin G autoantibody against the aquaporin-4 water channel&#x000a0;<xref ref-type="bibr" rid="article-31355.r23">[23]</xref>&#x000a0;or the myelin oligodendrocyte glycoprotein. No antibodies are pertinent in a subset of NMOSD (double-seronegative disease).</p>
        <p>The exact mechanism of the pathophysiology of acute disseminated encephalomyelitis is still unknown. However, it has been related to inflammation initiated by infection or vaccination in genetically susceptible individuals, causing demyelination. Progressive multifocal leukoencephalopathy is a central demyelinating disease caused by reactivation (usually occurs at CD4 count less than 200/cm) of latent JC polyomavirus (or John Cunningham virus or human polyomavirus 2) in oligodendrocytes in patients with human immunodeficiency virus. Leukodystrophy causes white matter lesions secondary to substrate accumulation due to enzymatic defects causing demyelination.</p>
        <p>Traumatic axonal injury refers to severe axonal mechanical damage due to a rotational acceleration of the brain. Although its pathophysiology is complicated, the injury damage is firstly due to a mechanical break involving axonal microtubules. This stretch induces axonal damage through undulations, breaks, and direct membrane mechanoporation with calcium influx. This mechanism leads to the activation of several injurious pathways, including caspase-mediated proteolysis and cytokine-mediated microglia recruitment with impairment of axonal transport and the aggregation of transported proteins in varicose swellings.<xref ref-type="bibr" rid="article-31355.r24">[24]</xref></p>
      </sec>
      <sec id="article-31355.s6" sec-type="History and Physical">
        <title>History and Physical</title>
        <p>Clinical presentation can vary from asymptomatic to patients with disabling disease as per the white matter lesions etiology. Older patients with small punctate cerebral vascular white matter lesions are usually asymptomatic, but they progress to large confluent lesions and can present with subtle functional decline, cognitive impairment, dementia, urinary incontinence, gait and balance impairment, and neuropsychiatric disorders. Within the group of vascular WM diseases, the distribution of lesions varies greatly, and consequently, the clinical aspects. For instance, in small vessel disease, the WMHs are mainly found in basal ganglia and frontotemporal and periventricular WM; these may induce cognitive impairment, loss of balance or coordination, vision loss, and dizziness. Severe headaches can be present in different types of white matter lesions.</p>
        <p>Patients with non-vascular etiology of white matter lesions like MS can have heterogeneous presentations, including fatigue, unilateral visual blurring, sensory changes, motor abnormality, urinary incontinence, speech and swallowing difficulties, pain, anxiety, depression, numbness and tingling, and cognitive dysfunction. Nevertheless, the clinical scenario and evolution of the disease vary from patient to patient. Some patients deteriorate rapidly, while in others, an alternation between relapses and remissions is observed.</p>
        <p>Clinical aspects of NMOSD include acute attacks of bilateral optic neuritis with significant visual loss or transverse myelitis, inducing limb weakness, sensory loss, and bladder dysfunction. Other symptoms can consist of episodes of intractable nausea, vomiting, hiccups, excessive daytime somnolence or narcolepsy, and seizures. Commonly relapsing courses and variable degrees of recovery occur within weeks to months.<xref ref-type="bibr" rid="article-31355.r25">[25]</xref></p>
        <p>Children with white matter lesions presenting with progressive symptoms of declining developmental milestones, cognitive impairment, and motor abnormalities should be suspected of leukodystrophy. However, patients in their first or second decade with white matter lesions secondary to acute disseminated encephalomyelitis present with acute onset and rapidly progressive symptoms of fever, headache, vomiting, confusion, or altered sensorium. Although migraine was associated with structural changes in the brain WM, these lesions are generally not linked to any neurological issues, as well as an increased risk of cognitive decline.<xref ref-type="bibr" rid="article-31355.r26">[26]</xref></p>
      </sec>
      <sec id="article-31355.s7" sec-type="Evaluation">
        <title>Evaluation</title>
        <p>Evaluating patients presenting with white matter lesions depends on the patient's age, clinical scenario, and pattern of white matter lesions on MRI, which are common manifestations of cerebral small vessel disease and are associated with vascular risk factors. These patients should be screened for vascular risk factors by routine laboratory tests, including a complete metabolic panel, lipid profile, and HbA1c. Also, it is worthwhile to quantify white matter lesions to monitor their progress with time in these patients. Various grading scales like the Fazekas scale and age-related white matter changes rating scale can be used to assess the extent and progression of white matter lesions (see&#x000a0;<bold>Image.&#x000a0;</bold>Fazekas Grade 3 White Matter Lesions).<xref ref-type="bibr" rid="article-31355.r27">[27]</xref><xref ref-type="bibr" rid="article-31355.r28">[28]</xref><xref ref-type="bibr" rid="article-31355.r29">[29]</xref></p>
        <p>Patients with non-vascular white matter lesions require further evaluation to identify the etiology of the lesions. Cerebral spinal fluid analysis is helpful in cases of suspected MS (oligoclonal bands), Acute disseminated encephalomyelitis (ADEM; lymphocytic pleocytosis with raised proteins), and infectious demyelination (antiviral antibodies). MR spectroscopy can help in the etiological diagnosis of white matter lesions to differentiate lesions based on different metabolite peaks.</p>
        <p>Additional tests like serology for autoantibodies in case of suspected vasculitis, anti-myelin oligodendrocyte glycoprotein antibodies in ADEM, and anti-AQP4 antibodies in NMOSD. Also, metabolic and toxicology screens can be helpful in suspected cases. Children with white matter lesions and clinical scenarios for leukodystrophy require genetic testing.<xref ref-type="bibr" rid="article-31355.r30">[30]</xref></p>
      </sec>
      <sec id="article-31355.s8" sec-type="Treatment / Management">
        <title>Treatment / Management</title>
        <p>White matter lesions in older adults most commonly reflect underlying small vessel ischemic lesions and, more probably, cognitive dysfunction. Proper management may prevent further deterioration by targeting all vascular risk factors.<xref ref-type="bibr" rid="article-31355.r31">[31]</xref>&#x000a0;White matter lesions detected incidentally on MRI of older patients require management of vascular risk factors by:</p>
        <list list-type="bullet">
          <list-item>
            <p>Intensively controlling the blood pressure</p>
          </list-item>
          <list-item>
            <p>Strict diabetes control</p>
          </list-item>
          <list-item>
            <p>Improving dyslipidemia</p>
          </list-item>
          <list-item>
            <p>Promoting physical fitness</p>
          </list-item>
          <list-item>
            <p>Avoiding smoking</p>
          </list-item>
          <list-item>
            <p>Avoiding alcohol</p>
          </list-item>
          <list-item>
            <p>Use of antiplatelets&#x000a0;</p>
          </list-item>
        </list>
        <p>Prophylaxis of migraine with aura can also help decrease the risk of white matter lesions. Using B vitamins to lower homocysteine levels is useful in managing patients with small vessel disease. Managing non-vascular white matter lesions is individualized as per etiology. White matter lesions secondary to MS flares are treated with steroids. However, patients need long-term maintenance therapy with disease-modifying treatment to halt disease progression.</p>
        <p>Furthermore, immunosuppression with high-dose intravenous glucocorticoids is used in patients with ADEM. Acyclovir has also been reported to have benefits in some cases. Leukodystrophies do not have a specific treatment; treatment is only supportive and symptomatic. Other white matter lesions caused by specific diseases, such as progressive multifocal leukoencephalopathy (PML), human immunodeficiency virus (HIV), and gliomas, must be treated for those specific causes.</p>
      </sec>
      <sec id="article-31355.s9" sec-type="Differential Diagnosis">
        <title>Differential Diagnosis</title>
        <p>Pattern recognition of white matter lesions in MRI is crucial as it may make the diagnosis in many conditions.<xref ref-type="bibr" rid="article-31355.r32">[32]</xref></p>
        <p>The differential diagnosis for symmetric white matter lesions can include:</p>
        <list list-type="bullet">
          <list-item>
            <p>Bilateral hemispheres: toxic encephalopathy, HIV encephalopathy, autoimmune encephalopathies, and vitamin B12 deficiency</p>
          </list-item>
          <list-item>
            <p>Periventricular lesions: small vessel disease, HIV encephalopathy, vitamin B12 deficiency, metachromatic leukodystrophy, X-linked adrenoleukodystrophy, and vanishing white matter disease</p>
          </list-item>
          <list-item>
            <p>Subcortical including arcuate fibers: Alexander disease, Kearns-Sayre syndrome, and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL)</p>
          </list-item>
          <list-item>
            <p>Frontal predominance: Alexander disease and metachromatic leukodystrophy</p>
          </list-item>
          <list-item>
            <p>Parietal/temporal/occipital lobes: posterior reversible encephalopathy, heroin abuse, and Krabbe disease</p>
          </list-item>
          <list-item>
            <p>Corpus callosum: Marchifava-Bignami disease, metachromatic leukodystrophy, and Krabbe disease</p>
          </list-item>
          <list-item>
            <p>Cerebellum: toxic encephalopathy and mitochondriopathies</p>
          </list-item>
          <list-item>
            <p>Central pons: central pontine myelinolysis&#x000a0;</p>
          </list-item>
        </list>
        <p>The differential diagnosis for asymmetric white matter lesions:</p>
        <list list-type="bullet">
          <list-item>
            <p>Patchy multifocal confluent lesion: MS, autoimmune encephalopathies, and CADASIL</p>
          </list-item>
          <list-item>
            <p>Parieto-occipital regions: PML</p>
          </list-item>
        </list>
      </sec>
      <sec id="article-31355.s10" sec-type="Prognosis">
        <title>Prognosis</title>
        <p>The prognosis of patients with&#x000a0;white matter lesions&#x000a0;depends on the etiology of the lesions. Patients with age-related&#x000a0;white matter lesions are irreversible and progressive. Large and confluent&#x000a0;white matter lesions have a poor prognosis and lead to cognitive impairment and global functional decline.<xref ref-type="bibr" rid="article-31355.r33">[33]</xref></p>
        <p>White matter lesions&#x000a0;secondary to MS have interpatient variability in prognosis. Severe disabilities are present in 5% of patients within the first&#x000a0;5 years of onset, and 10% to 20% of patients of MS remain unimpaired without therapy after 20 years.<xref ref-type="bibr" rid="article-31355.r34">[34]</xref> NMO and ADEM have a variable prognosis from complete recovery to the development of permanent physical disability, especially in post-measles ADEM.<xref ref-type="bibr" rid="article-31355.r35">[35]</xref>&#x000a0;Acute demyelinating disease prognosis depends upon the severity of the initial illness. Patients responding to treatment have a favorable prognosis. However, leukodystrophies have a poor prognosis. Reversible causes, including metabolic and toxic encephalopathies, have a good prognosis.</p>
      </sec>
      <sec id="article-31355.s11" sec-type="Complications">
        <title>Complications</title>
        <p>Severe white matter lesions are associated with cognitive impairment, global functional decline, cerebrovascular accident, mood disorders,&#x000a0;gait, and balance dysfunction.&#x000a0;White matter lesions are also associated with grey matter atrophy and accelerated neurodegeneration.<xref ref-type="bibr" rid="article-31355.r36">[36]</xref>&#x000a0;Furthermore, severe, extensive involvement of white matter by non-vascular causes like MS, ADEM, and NMO causes disability.</p>
      </sec>
      <sec id="article-31355.s12" sec-type="Deterrence and Patient Education">
        <title>Deterrence and Patient Education</title>
        <p>Patients with vascular risk factors should be identified early and counseled on lifestyle changes and control of comorbid conditions. Self-monitoring of blood pressure and blood sugar, dietary modifications, weight reduction, and improving physical fitness have proven to decrease the progression of white matter lesions.<xref ref-type="bibr" rid="article-31355.r37">[37]</xref>&#x000a0;Involvement in cognitively complex leisure activity to improve cognitive reserve has been associated with a protective effect on cognitive functioning and late-life depression in patients with white matter lesions.<xref ref-type="bibr" rid="article-31355.r38">[38]</xref></p>
      </sec>
      <sec id="article-31355.s13" sec-type="Enhancing Healthcare Team Outcomes ">
        <title>Enhancing Healthcare Team Outcomes </title>
        <p>As described, white matter lesions have varied clinical presentations, differential diagnoses, and complications. Managing these conditions require extensive collaboration and coordination among a team of professionals, which consists of neurologists, radiologists, internists, ophthalmologists, psychiatrists, neurosurgeons, rheumatologists, microbiologists, pain specialists, nurse specialists, mental health nurses, pharmacists, physical therapists, and nutritionists. Clear and effective communication between these professionals while monitoring the progression and complications of&#x000a0;white matter lesions can decrease mortality.</p>
      </sec>
      <sec id="article-31355.s14">
        <title>Review Questions</title>
        <list list-type="bullet">
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/account/trialuserreg/?articleid=31355&#x00026;utm_source=pubmed&#x00026;utm_campaign=reviews&#x00026;utm_content=31355">Access free multiple choice questions on this topic.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://mdsearchlight.com/neurology/white-matter-lesions/?utm_source=pubmedlink&#x00026;utm_campaign=MDS&#x00026;utm_content=31355">Click here for a simplified version.</ext-link>
</p>
          </list-item>
          <list-item>
            <p>
<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://www.statpearls.com/articlelibrary/commentarticle/31355/?utm_source=pubmed&#x00026;utm_campaign=comments&#x00026;utm_content=31355">Comment on this article.</ext-link>
</p>
          </list-item>
        </list>
      </sec>
    </body>
    <back>
      <floats-group id="article-31355.s15">
        <fig id="article-31355.image.f1" position="float" orientation="portrait">
          <caption>
            <p>Fazekas Grade 3 White Matter Lesions. Fazekas grade&#x000a0;3 white matter lesions in a case of stroke. Contributed by S Munakomi, MD</p>
          </caption>
          <graphic xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="wml" position="float" orientation="portrait"/>
        </fig>
      </floats-group>
      <ref-list id="article-31355.s16">
        <title>References</title>
        <ref id="article-31355.r1">
          <label>1</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Filley</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Fields</surname>
                <given-names>RD</given-names>
              </name>
            </person-group>
            <article-title>White matter and cognition: making the connection.</article-title>
            <source>J Neurophysiol</source>
            <year>2016</year>
            <month>Nov</month>
            <day>01</day>
            <volume>116</volume>
            <issue>5</issue>
            <fpage>2093</fpage>
            <page-range>2093-2104</page-range>
            <pub-id pub-id-type="pmid">27512019</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r2">
          <label>2</label>
          <element-citation publication-type="book">
            <person-group person-group-type="author">
              <name>
                <surname>Muzio</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Fakoya</surname>
                <given-names>AO</given-names>
              </name>
              <name>
                <surname>Cascella</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <chapter-title>Histology, Axon</chapter-title>
            <source>StatPearls [Internet]</source>
            <publisher-name>StatPearls Publishing</publisher-name>
            <publisher-loc>Treasure Island (FL)</publisher-loc>
            <year>2022</year>
            <month>11</month>
            <day>14</day>
            <pub-id pub-id-type="pmid">32119275</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r3">
          <label>3</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Nave</surname>
                <given-names>KA</given-names>
              </name>
              <name>
                <surname>Werner</surname>
                <given-names>HB</given-names>
              </name>
            </person-group>
            <article-title>Myelination of the nervous system: mechanisms and functions.</article-title>
            <source>Annu Rev Cell Dev Biol</source>
            <year>2014</year>
            <volume>30</volume>
            <fpage>503</fpage>
            <page-range>503-33</page-range>
            <pub-id pub-id-type="pmid">25288117</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r4">
          <label>4</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hachinski</surname>
                <given-names>VC</given-names>
              </name>
              <name>
                <surname>Potter</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Merskey</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>Leuko-araiosis: an ancient term for a new problem.</article-title>
            <source>Can J Neurol Sci</source>
            <year>1986</year>
            <month>Nov</month>
            <volume>13</volume>
            <issue>4 Suppl</issue>
            <fpage>533</fpage>
            <page-range>533-4</page-range>
            <pub-id pub-id-type="pmid">3791068</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r5">
          <label>5</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Firbank</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Teodorczuk</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>van der Flier</surname>
                <given-names>WM</given-names>
              </name>
              <name>
                <surname>Gouw</surname>
                <given-names>AA</given-names>
              </name>
              <name>
                <surname>Wallin</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Erkinjuntti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Inzitari</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Wahlund</surname>
                <given-names>LO</given-names>
              </name>
              <name>
                <surname>Pantoni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Poggesi</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Pracucci</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Langhorne</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>O'Brien</surname>
                <given-names>JT</given-names>
              </name>
              <collab>LADIS group</collab>
            </person-group>
            <article-title>Relationship between progression of brain white matter changes and late-life depression: 3-year results from the LADIS study.</article-title>
            <source>Br J Psychiatry</source>
            <year>2012</year>
            <month>Jul</month>
            <volume>201</volume>
            <issue>1</issue>
            <fpage>40</fpage>
            <page-range>40-5</page-range>
            <pub-id pub-id-type="pmid">22626634</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r6">
          <label>6</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Debette</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Beiser</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>DeCarli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Au</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Himali</surname>
                <given-names>JJ</given-names>
              </name>
              <name>
                <surname>Kelly-Hayes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Kase</surname>
                <given-names>CS</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Seshadri</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Association of MRI markers of vascular brain injury with incident stroke, mild cognitive impairment, dementia, and mortality: the Framingham Offspring Study.</article-title>
            <source>Stroke</source>
            <year>2010</year>
            <month>Apr</month>
            <volume>41</volume>
            <issue>4</issue>
            <fpage>600</fpage>
            <page-range>600-6</page-range>
            <pub-id pub-id-type="pmid">20167919</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r7">
          <label>7</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Debette</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Markus</surname>
                <given-names>HS</given-names>
              </name>
            </person-group>
            <article-title>The clinical importance of white matter hyperintensities on brain magnetic resonance imaging: systematic review and meta-analysis.</article-title>
            <source>BMJ</source>
            <year>2010</year>
            <month>Jul</month>
            <day>26</day>
            <volume>341</volume>
            <fpage>c3666</fpage>
            <pub-id pub-id-type="pmid">20660506</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r8">
          <label>8</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kang</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Stewart</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Park</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Bae</surname>
                <given-names>KY</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>SW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Shin</surname>
                <given-names>IS</given-names>
              </name>
              <name>
                <surname>Cho</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Yoon</surname>
                <given-names>JS</given-names>
              </name>
            </person-group>
            <article-title>White matter hyperintensities and functional outcomes at 2 weeks and 1 year after stroke.</article-title>
            <source>Cerebrovasc Dis</source>
            <year>2013</year>
            <volume>35</volume>
            <issue>2</issue>
            <fpage>138</fpage>
            <page-range>138-45</page-range>
            <pub-id pub-id-type="pmid">23406918</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r9">
          <label>9</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Atchaneeyasakul</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Leslie-Mazwi</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Donahue</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Giese</surname>
                <given-names>AK</given-names>
              </name>
              <name>
                <surname>Rost</surname>
                <given-names>NS</given-names>
              </name>
            </person-group>
            <article-title>White Matter Hyperintensity Volume and Outcome of Mechanical Thrombectomy With Stentriever in Acute Ischemic Stroke.</article-title>
            <source>Stroke</source>
            <year>2017</year>
            <month>Oct</month>
            <volume>48</volume>
            <issue>10</issue>
            <fpage>2892</fpage>
            <page-range>2892-2894</page-range>
            <pub-id pub-id-type="pmid">28887393</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r10">
          <label>10</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Smith</surname>
                <given-names>EE</given-names>
              </name>
              <name>
                <surname>Saposnik</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Biessels</surname>
                <given-names>GJ</given-names>
              </name>
              <name>
                <surname>Doubal</surname>
                <given-names>FN</given-names>
              </name>
              <name>
                <surname>Fornage</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Gorelick</surname>
                <given-names>PB</given-names>
              </name>
              <name>
                <surname>Greenberg</surname>
                <given-names>SM</given-names>
              </name>
              <name>
                <surname>Higashida</surname>
                <given-names>RT</given-names>
              </name>
              <name>
                <surname>Kasner</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Seshadri</surname>
                <given-names>S</given-names>
              </name>
              <collab>American Heart Association Stroke Council; Council on Cardiovascular Radiology and Intervention; Council on Functional Genomics and Translational Biology; and Council on Hypertension</collab>
            </person-group>
            <article-title>Prevention of Stroke in Patients With Silent Cerebrovascular Disease: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association.</article-title>
            <source>Stroke</source>
            <year>2017</year>
            <month>Feb</month>
            <volume>48</volume>
            <issue>2</issue>
            <fpage>e44</fpage>
            <page-range>e44-e71</page-range>
            <pub-id pub-id-type="pmid">27980126</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r11">
          <label>11</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Zhuang</surname>
                <given-names>FJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>He</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Cai</surname>
                <given-names>ZY</given-names>
              </name>
            </person-group>
            <article-title>Prevalence of white matter hyperintensities increases with age.</article-title>
            <source>Neural Regen Res</source>
            <year>2018</year>
            <month>Dec</month>
            <volume>13</volume>
            <issue>12</issue>
            <fpage>2141</fpage>
            <page-range>2141-2146</page-range>
            <pub-id pub-id-type="pmid">30323144</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r12">
          <label>12</label>
          <element-citation publication-type="journal">
            <collab>GBD 2016 Multiple Sclerosis Collaborators</collab>
            <article-title>Global, regional, and national burden of multiple sclerosis 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016.</article-title>
            <source>Lancet Neurol</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>18</volume>
            <issue>3</issue>
            <fpage>269</fpage>
            <page-range>269-285</page-range>
            <pub-id pub-id-type="pmid">30679040</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r13">
          <label>13</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hor</surname>
                <given-names>JY</given-names>
              </name>
              <name>
                <surname>Asgari</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Nakashima</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Broadley</surname>
                <given-names>SA</given-names>
              </name>
              <name>
                <surname>Leite</surname>
                <given-names>MI</given-names>
              </name>
              <name>
                <surname>Kissani</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Jacob</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Marignier</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Weinshenker</surname>
                <given-names>BG</given-names>
              </name>
              <name>
                <surname>Paul</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Pittock</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Palace</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wingerchuk</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Behne</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Yeaman</surname>
                <given-names>MR</given-names>
              </name>
              <name>
                <surname>Fujihara</surname>
                <given-names>K</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology of Neuromyelitis Optica Spectrum Disorder and Its Prevalence and Incidence Worldwide.</article-title>
            <source>Front Neurol</source>
            <year>2020</year>
            <volume>11</volume>
            <fpage>501</fpage>
            <pub-id pub-id-type="pmid">32670177</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r14">
          <label>14</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Diwanji</surname>
                <given-names>TP</given-names>
              </name>
              <name>
                <surname>Engelman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Snider</surname>
                <given-names>JW</given-names>
              </name>
              <name>
                <surname>Mohindra</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Epidemiology, diagnosis, and optimal management of glioma in adolescents and young adults.</article-title>
            <source>Adolesc Health Med Ther</source>
            <year>2017</year>
            <volume>8</volume>
            <fpage>99</fpage>
            <page-range>99-113</page-range>
            <pub-id pub-id-type="pmid">28989289</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r15">
          <label>15</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Bonkowsky</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Nelson</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Kingston</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Filloux</surname>
                <given-names>FM</given-names>
              </name>
              <name>
                <surname>Mundorff</surname>
                <given-names>MB</given-names>
              </name>
              <name>
                <surname>Srivastava</surname>
                <given-names>R</given-names>
              </name>
            </person-group>
            <article-title>The burden of inherited leukodystrophies in children.</article-title>
            <source>Neurology</source>
            <year>2010</year>
            <month>Aug</month>
            <day>24</day>
            <volume>75</volume>
            <issue>8</issue>
            <fpage>718</fpage>
            <page-range>718-25</page-range>
            <pub-id pub-id-type="pmid">20660364</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r16">
          <label>16</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Langer-Gould</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Chung</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Yeung</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Waubant</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Yao</surname>
                <given-names>J</given-names>
              </name>
            </person-group>
            <article-title>Incidence of acquired CNS demyelinating syndromes in a multiethnic cohort of children.</article-title>
            <source>Neurology</source>
            <year>2011</year>
            <month>Sep</month>
            <day>20</day>
            <volume>77</volume>
            <issue>12</issue>
            <fpage>1143</fpage>
            <page-range>1143-8</page-range>
            <pub-id pub-id-type="pmid">21865580</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r17">
          <label>17</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fornage</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Debette</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bis</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ikram</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Dufouil</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Sigurdsson</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Lumley</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>DeStefano</surname>
                <given-names>AL</given-names>
              </name>
              <name>
                <surname>Fazekas</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Vrooman</surname>
                <given-names>HA</given-names>
              </name>
              <name>
                <surname>Shibata</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Maillard</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Zijdenbos</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>AV</given-names>
              </name>
              <name>
                <surname>Gudnason</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>de Boer</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Cushman</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Mazoyer</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Heiss</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Vernooij</surname>
                <given-names>MW</given-names>
              </name>
              <name>
                <surname>Enzinger</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Glazer</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Beiser</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Knopman</surname>
                <given-names>DS</given-names>
              </name>
              <name>
                <surname>Cavalieri</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Niessen</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Harris</surname>
                <given-names>TB</given-names>
              </name>
              <name>
                <surname>Petrovic</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Lopez</surname>
                <given-names>OL</given-names>
              </name>
              <name>
                <surname>Au</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Lambert</surname>
                <given-names>JC</given-names>
              </name>
              <name>
                <surname>Hofman</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Gottesman</surname>
                <given-names>RF</given-names>
              </name>
              <name>
                <surname>Garcia</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Heckbert</surname>
                <given-names>SR</given-names>
              </name>
              <name>
                <surname>Atwood</surname>
                <given-names>LD</given-names>
              </name>
              <name>
                <surname>Catellier</surname>
                <given-names>DJ</given-names>
              </name>
              <name>
                <surname>Uitterlinden</surname>
                <given-names>AG</given-names>
              </name>
              <name>
                <surname>Yang</surname>
                <given-names>Q</given-names>
              </name>
              <name>
                <surname>Smith</surname>
                <given-names>NL</given-names>
              </name>
              <name>
                <surname>Aspelund</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Romero</surname>
                <given-names>JR</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Taylor</surname>
                <given-names>KD</given-names>
              </name>
              <name>
                <surname>Nalls</surname>
                <given-names>MA</given-names>
              </name>
              <name>
                <surname>Rotter</surname>
                <given-names>JI</given-names>
              </name>
              <name>
                <surname>Sharrett</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>van Duijn</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Amouyel</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Wolf</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Gudnason</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>van der Lugt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Boerwinkle</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Psaty</surname>
                <given-names>BM</given-names>
              </name>
              <name>
                <surname>Seshadri</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Tzourio</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Breteler</surname>
                <given-names>MM</given-names>
              </name>
              <name>
                <surname>Mosley</surname>
                <given-names>TH</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Longstreth</surname>
                <given-names>WT</given-names>
              </name>
              <name>
                <surname>DeCarli</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Launer</surname>
                <given-names>LJ</given-names>
              </name>
            </person-group>
            <article-title>Genome-wide association studies of cerebral white matter lesion burden: the CHARGE consortium.</article-title>
            <source>Ann Neurol</source>
            <year>2011</year>
            <month>Jun</month>
            <volume>69</volume>
            <issue>6</issue>
            <fpage>928</fpage>
            <page-range>928-39</page-range>
            <pub-id pub-id-type="pmid">21681796</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r18">
          <label>18</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Fennema-Notestine</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>McEvoy</surname>
                <given-names>LK</given-names>
              </name>
              <name>
                <surname>Notestine</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Panizzon</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>Yau</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Franz</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Lyons</surname>
                <given-names>MJ</given-names>
              </name>
              <name>
                <surname>Eyler</surname>
                <given-names>LT</given-names>
              </name>
              <name>
                <surname>Neale</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Xian</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>McKenzie</surname>
                <given-names>RE</given-names>
              </name>
              <name>
                <surname>Kremen</surname>
                <given-names>WS</given-names>
              </name>
            </person-group>
            <article-title>White matter disease in midlife is heritable, related to hypertension, and shares some genetic influence with systolic blood pressure.</article-title>
            <source>Neuroimage Clin</source>
            <year>2016</year>
            <volume>12</volume>
            <fpage>737</fpage>
            <page-range>737-745</page-range>
            <pub-id pub-id-type="pmid">27790395</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r19">
          <label>19</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Wang</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Lan</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>Y</given-names>
              </name>
            </person-group>
            <article-title>Multiple Factors Involved in the Pathogenesis of White Matter Lesions.</article-title>
            <source>Biomed Res Int</source>
            <year>2017</year>
            <volume>2017</volume>
            <fpage>9372050</fpage>
            <pub-id pub-id-type="pmid">28316994</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r20">
          <label>20</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wardlaw</surname>
                <given-names>JM</given-names>
              </name>
              <name>
                <surname>Vald&#x000e9;s Hern&#x000e1;ndez</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Mu&#x000f1;oz-Maniega</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>What are white matter hyperintensities made of? Relevance to vascular cognitive impairment.</article-title>
            <source>J Am Heart Assoc</source>
            <year>2015</year>
            <month>Jun</month>
            <day>23</day>
            <volume>4</volume>
            <issue>6</issue>
            <fpage>001140</fpage>
            <pub-id pub-id-type="pmid">26104658</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r21">
          <label>21</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Huang</surname>
                <given-names>WJ</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>WW</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>X</given-names>
              </name>
            </person-group>
            <article-title>Multiple sclerosis: Pathology, diagnosis and treatments.</article-title>
            <source>Exp Ther Med</source>
            <year>2017</year>
            <month>Jun</month>
            <volume>13</volume>
            <issue>6</issue>
            <fpage>3163</fpage>
            <page-range>3163-3166</page-range>
            <pub-id pub-id-type="pmid">28588671</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r22">
          <label>22</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Papadopoulos</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Magliozzi</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Mitsikostas</surname>
                <given-names>DD</given-names>
              </name>
              <name>
                <surname>Gorgoulis</surname>
                <given-names>VG</given-names>
              </name>
              <name>
                <surname>Nicholas</surname>
                <given-names>RS</given-names>
              </name>
            </person-group>
            <article-title>Aging, Cellular Senescence, and Progressive Multiple Sclerosis.</article-title>
            <source>Front Cell Neurosci</source>
            <year>2020</year>
            <volume>14</volume>
            <fpage>178</fpage>
            <pub-id pub-id-type="pmid">32694983</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r23">
          <label>23</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lennon</surname>
                <given-names>VA</given-names>
              </name>
              <name>
                <surname>Wingerchuk</surname>
                <given-names>DM</given-names>
              </name>
              <name>
                <surname>Kryzer</surname>
                <given-names>TJ</given-names>
              </name>
              <name>
                <surname>Pittock</surname>
                <given-names>SJ</given-names>
              </name>
              <name>
                <surname>Lucchinetti</surname>
                <given-names>CF</given-names>
              </name>
              <name>
                <surname>Fujihara</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Nakashima</surname>
                <given-names>I</given-names>
              </name>
              <name>
                <surname>Weinshenker</surname>
                <given-names>BG</given-names>
              </name>
            </person-group>
            <article-title>A serum autoantibody marker of neuromyelitis optica: distinction from multiple sclerosis.</article-title>
            <source>Lancet</source>
            <year>2004</year>
            <month>Dec</month>
            <day>11-17</day>
            <volume>364</volume>
            <issue>9451</issue>
            <fpage>2106</fpage>
            <page-range>2106-12</page-range>
            <pub-id pub-id-type="pmid">15589308</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r24">
          <label>24</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Mohammadian</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Roine</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Hirvonen</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Kurki</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Posti</surname>
                <given-names>JP</given-names>
              </name>
              <name>
                <surname>Katila</surname>
                <given-names>AJ</given-names>
              </name>
              <name>
                <surname>Takala</surname>
                <given-names>RSK</given-names>
              </name>
              <name>
                <surname>Tallus</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Maanp&#x000e4;&#x000e4;</surname>
                <given-names>HR</given-names>
              </name>
              <name>
                <surname>Frantz&#x000e9;n</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Hutchinson</surname>
                <given-names>PJ</given-names>
              </name>
              <name>
                <surname>Newcombe</surname>
                <given-names>VF</given-names>
              </name>
              <name>
                <surname>Menon</surname>
                <given-names>DK</given-names>
              </name>
              <name>
                <surname>Tenovuo</surname>
                <given-names>O</given-names>
              </name>
            </person-group>
            <article-title>Alterations in Microstructure and Local Fiber Orientation of White Matter Are Associated with Outcome after Mild Traumatic Brain Injury.</article-title>
            <source>J Neurotrauma</source>
            <year>2020</year>
            <month>Dec</month>
            <day>15</day>
            <volume>37</volume>
            <issue>24</issue>
            <fpage>2616</fpage>
            <page-range>2616-2623</page-range>
            <pub-id pub-id-type="pmid">32689872</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r25">
          <label>25</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lock</surname>
                <given-names>JH</given-names>
              </name>
              <name>
                <surname>Newman</surname>
                <given-names>NJ</given-names>
              </name>
              <name>
                <surname>Biousse</surname>
                <given-names>V</given-names>
              </name>
              <name>
                <surname>Peragallo</surname>
                <given-names>JH</given-names>
              </name>
            </person-group>
            <article-title>Update on pediatric optic neuritis.</article-title>
            <source>Curr Opin Ophthalmol</source>
            <year>2019</year>
            <month>Nov</month>
            <volume>30</volume>
            <issue>6</issue>
            <fpage>418</fpage>
            <page-range>418-425</page-range>
            <pub-id pub-id-type="pmid">31433309</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r26">
          <label>26</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Guidetti</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Rota</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Morelli</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Immovilli</surname>
                <given-names>P</given-names>
              </name>
            </person-group>
            <article-title>Migraine and stroke: "vascular" comorbidity.</article-title>
            <source>Front Neurol</source>
            <year>2014</year>
            <volume>5</volume>
            <fpage>193</fpage>
            <pub-id pub-id-type="pmid">25339937</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r27">
          <label>27</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Kim</surname>
                <given-names>TW</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>YH</given-names>
              </name>
              <name>
                <surname>Kim</surname>
                <given-names>KH</given-names>
              </name>
              <name>
                <surname>Chang</surname>
                <given-names>WH</given-names>
              </name>
            </person-group>
            <article-title>White matter hyperintensities and cognitive dysfunction in patients with infratentorial stroke.</article-title>
            <source>Ann Rehabil Med</source>
            <year>2014</year>
            <month>Oct</month>
            <volume>38</volume>
            <issue>5</issue>
            <fpage>620</fpage>
            <page-range>620-7</page-range>
            <pub-id pub-id-type="pmid">25379491</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r28">
          <label>28</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>van Straaten</surname>
                <given-names>EC</given-names>
              </name>
              <name>
                <surname>Fazekas</surname>
                <given-names>F</given-names>
              </name>
              <name>
                <surname>Rostrup</surname>
                <given-names>E</given-names>
              </name>
              <name>
                <surname>Scheltens</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Pantoni</surname>
                <given-names>L</given-names>
              </name>
              <name>
                <surname>Inzitari</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Waldemar</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Erkinjuntti</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>M&#x000e4;ntyl&#x000e4;</surname>
                <given-names>R</given-names>
              </name>
              <name>
                <surname>Wahlund</surname>
                <given-names>LO</given-names>
              </name>
              <name>
                <surname>Barkhof</surname>
                <given-names>F</given-names>
              </name>
              <collab>LADIS Group</collab>
            </person-group>
            <article-title>Impact of white matter hyperintensities scoring method on correlations with clinical data: the LADIS study.</article-title>
            <source>Stroke</source>
            <year>2006</year>
            <month>Mar</month>
            <volume>37</volume>
            <issue>3</issue>
            <fpage>836</fpage>
            <page-range>836-40</page-range>
            <pub-id pub-id-type="pmid">16439704</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r29">
          <label>29</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Andere</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Jindal</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Molino</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Collins</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Merck</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Burton</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Stretz</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Yaghi</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Sacchetti</surname>
                <given-names>DC</given-names>
              </name>
              <name>
                <surname>Jamal</surname>
                <given-names>SE</given-names>
              </name>
              <name>
                <surname>Reznik</surname>
                <given-names>ME</given-names>
              </name>
              <name>
                <surname>Furie</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Cutting</surname>
                <given-names>S</given-names>
              </name>
            </person-group>
            <article-title>Volumetric White Matter Hyperintensity Ranges Correspond to Fazekas Scores on Brain MRI.</article-title>
            <source>J Stroke Cerebrovasc Dis</source>
            <year>2022</year>
            <month>Apr</month>
            <volume>31</volume>
            <issue>4</issue>
            <fpage>106333</fpage>
            <pub-id pub-id-type="pmid">35158149</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r30">
          <label>30</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Parikh</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>Bernard</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Leventer</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>van der Knaap</surname>
                <given-names>MS</given-names>
              </name>
              <name>
                <surname>van Hove</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Pizzino</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>McNeill</surname>
                <given-names>NH</given-names>
              </name>
              <name>
                <surname>Helman</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Simons</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Schmidt</surname>
                <given-names>JL</given-names>
              </name>
              <name>
                <surname>Rizzo</surname>
                <given-names>WB</given-names>
              </name>
              <name>
                <surname>Patterson</surname>
                <given-names>MC</given-names>
              </name>
              <name>
                <surname>Taft</surname>
                <given-names>RJ</given-names>
              </name>
              <name>
                <surname>Vanderver</surname>
                <given-names>A</given-names>
              </name>
              <collab>GLIA Consortium</collab>
            </person-group>
            <article-title>A clinical approach to the diagnosis of patients with leukodystrophies and genetic leukoencephelopathies.</article-title>
            <source>Mol Genet Metab</source>
            <year>2015</year>
            <month>Apr</month>
            <volume>114</volume>
            <issue>4</issue>
            <fpage>501</fpage>
            <page-range>501-515</page-range>
            <pub-id pub-id-type="pmid">25655951</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r31">
          <label>31</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Filley</surname>
                <given-names>CM</given-names>
              </name>
            </person-group>
            <article-title>Cognitive Dysfunction in White Matter Disorders: New Perspectives in Treatment and Recovery.</article-title>
            <source>J Neuropsychiatry Clin Neurosci</source>
            <year>2021</year>
            <season>Fall</season>
            <volume>33</volume>
            <issue>4</issue>
            <fpage>349</fpage>
            <page-range>349-355</page-range>
            <pub-id pub-id-type="pmid">34340526</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r32">
          <label>32</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Wildner</surname>
                <given-names>P</given-names>
              </name>
              <name>
                <surname>Stasio&#x00142;ek</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Matysiak</surname>
                <given-names>M</given-names>
              </name>
            </person-group>
            <article-title>Differential diagnosis of multiple sclerosis and other inflammatory CNS diseases.</article-title>
            <source>Mult Scler Relat Disord</source>
            <year>2020</year>
            <month>Jan</month>
            <volume>37</volume>
            <fpage>101452</fpage>
            <pub-id pub-id-type="pmid">31670010</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r33">
          <label>33</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Hasan</surname>
                <given-names>TF</given-names>
              </name>
              <name>
                <surname>Barrett</surname>
                <given-names>KM</given-names>
              </name>
              <name>
                <surname>Brott</surname>
                <given-names>TG</given-names>
              </name>
              <name>
                <surname>Badi</surname>
                <given-names>MK</given-names>
              </name>
              <name>
                <surname>Lesser</surname>
                <given-names>ER</given-names>
              </name>
              <name>
                <surname>Hodge</surname>
                <given-names>DO</given-names>
              </name>
              <name>
                <surname>Meschia</surname>
                <given-names>JF</given-names>
              </name>
            </person-group>
            <article-title>Severity of White Matter Hyperintensities and Effects on All-Cause Mortality in the Mayo Clinic Florida Familial Cerebrovascular Diseases Registry.</article-title>
            <source>Mayo Clin Proc</source>
            <year>2019</year>
            <month>Mar</month>
            <volume>94</volume>
            <issue>3</issue>
            <fpage>408</fpage>
            <page-range>408-416</page-range>
            <pub-id pub-id-type="pmid">30832790</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r34">
          <label>34</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Scalfari</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Neuhaus</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Degenhardt</surname>
                <given-names>A</given-names>
              </name>
              <name>
                <surname>Rice</surname>
                <given-names>GP</given-names>
              </name>
              <name>
                <surname>Muraro</surname>
                <given-names>PA</given-names>
              </name>
              <name>
                <surname>Daumer</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Ebers</surname>
                <given-names>GC</given-names>
              </name>
            </person-group>
            <article-title>The natural history of multiple sclerosis: a geographically based study 10: relapses and long-term disability.</article-title>
            <source>Brain</source>
            <year>2010</year>
            <month>Jul</month>
            <volume>133</volume>
            <issue>Pt 7</issue>
            <fpage>1914</fpage>
            <page-range>1914-29</page-range>
            <pub-id pub-id-type="pmid">20534650</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r35">
          <label>35</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Alexander</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Murthy</surname>
                <given-names>JM</given-names>
              </name>
            </person-group>
            <article-title>Acute disseminated encephalomyelitis: Treatment guidelines.</article-title>
            <source>Ann Indian Acad Neurol</source>
            <year>2011</year>
            <month>Jul</month>
            <volume>14</volume>
            <issue>Suppl 1</issue>
            <fpage>S60</fpage>
            <page-range>S60-4</page-range>
            <pub-id pub-id-type="pmid">21847331</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r36">
          <label>36</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Habes</surname>
                <given-names>M</given-names>
              </name>
              <name>
                <surname>Erus</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>Toledo</surname>
                <given-names>JB</given-names>
              </name>
              <name>
                <surname>Zhang</surname>
                <given-names>T</given-names>
              </name>
              <name>
                <surname>Bryan</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Launer</surname>
                <given-names>LJ</given-names>
              </name>
              <name>
                <surname>Rosseel</surname>
                <given-names>Y</given-names>
              </name>
              <name>
                <surname>Janowitz</surname>
                <given-names>D</given-names>
              </name>
              <name>
                <surname>Doshi</surname>
                <given-names>J</given-names>
              </name>
              <name>
                <surname>Van der Auwera</surname>
                <given-names>S</given-names>
              </name>
              <name>
                <surname>von Sarnowski</surname>
                <given-names>B</given-names>
              </name>
              <name>
                <surname>Hegenscheid</surname>
                <given-names>K</given-names>
              </name>
              <name>
                <surname>Hosten</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Homuth</surname>
                <given-names>G</given-names>
              </name>
              <name>
                <surname>V&#x000f6;lzke</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Schminke</surname>
                <given-names>U</given-names>
              </name>
              <name>
                <surname>Hoffmann</surname>
                <given-names>W</given-names>
              </name>
              <name>
                <surname>Grabe</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Davatzikos</surname>
                <given-names>C</given-names>
              </name>
            </person-group>
            <article-title>White matter hyperintensities and imaging patterns of brain ageing in the general population.</article-title>
            <source>Brain</source>
            <year>2016</year>
            <month>Apr</month>
            <volume>139</volume>
            <issue>Pt 4</issue>
            <fpage>1164</fpage>
            <page-range>1164-79</page-range>
            <pub-id pub-id-type="pmid">26912649</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r37">
          <label>37</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Sexton</surname>
                <given-names>CE</given-names>
              </name>
              <name>
                <surname>Betts</surname>
                <given-names>JF</given-names>
              </name>
              <name>
                <surname>Demnitz</surname>
                <given-names>N</given-names>
              </name>
              <name>
                <surname>Dawes</surname>
                <given-names>H</given-names>
              </name>
              <name>
                <surname>Ebmeier</surname>
                <given-names>KP</given-names>
              </name>
              <name>
                <surname>Johansen-Berg</surname>
                <given-names>H</given-names>
              </name>
            </person-group>
            <article-title>A systematic review of MRI studies examining the relationship between physical fitness and activity and the white matter of the ageing brain.</article-title>
            <source>Neuroimage</source>
            <year>2016</year>
            <month>May</month>
            <day>01</day>
            <volume>131</volume>
            <fpage>81</fpage>
            <page-range>81-90</page-range>
            <pub-id pub-id-type="pmid">26477656</pub-id>
          </element-citation>
        </ref>
        <ref id="article-31355.r38">
          <label>38</label>
          <element-citation publication-type="journal">
            <person-group>
              <name>
                <surname>Lin</surname>
                <given-names>C</given-names>
              </name>
              <name>
                <surname>Huang</surname>
                <given-names>CM</given-names>
              </name>
              <name>
                <surname>Fan</surname>
                <given-names>YT</given-names>
              </name>
              <name>
                <surname>Liu</surname>
                <given-names>HL</given-names>
              </name>
              <name>
                <surname>Chen</surname>
                <given-names>YL</given-names>
              </name>
              <name>
                <surname>Aizenstein</surname>
                <given-names>HJ</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>TM</given-names>
              </name>
              <name>
                <surname>Lee</surname>
                <given-names>SH</given-names>
              </name>
            </person-group>
            <article-title>Cognitive Reserve Moderates Effects of White Matter Hyperintensity on Depressive Symptoms and Cognitive Function in Late-Life Depression.</article-title>
            <source>Front Psychiatry</source>
            <year>2020</year>
            <volume>11</volume>
            <fpage>249</fpage>
            <pub-id pub-id-type="pmid">32322221</pub-id>
          </element-citation>
        </ref>
      </ref-list>
    </back>
  </book-part>
</book-part-wrapper>
